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Research
AbstrACt
Objective We set out to document how NHS trusts in the 
UK record and share disclosures of conflict of interest by 
their employees.
Design Cross-sectional study of responses to a Freedom 
of Information Act request for Gifts and Hospitality 
Registers.
setting NHS Trusts (secondary/tertiary care organisations) 
in England.
Participants 236 Trusts were contacted, of which 217 
responded.
Main outcome measures We assessed all disclosures for 
completeness and openness, scoring them for achieving 
each of five measures of transparency.
results 185 Trusts (78%) provided a register. 71 Trusts 
did not respond within the 28 day time limit required by 
the FoIA. Most COI registers were incomplete by design, 
and did not contain the information necessary to assess 
conflicts of interest. 126/185 (68%) did not record the 
names of recipients. 47/185 (25%) did not record the cash 
value of the gift or hospitality. Only 31/185 registers (16%) 
contained the names of recipients, the names of donors, 
and the cash amounts received. 18/185 (10%) contained 
none of: recipient name, donor name, and cash amount. 
Only 15 Trusts had their disclosure register publicly 
available online (6%). We generated a transparency index 
assessing whether each Trust met the following criteria: 
responded on time; provided a register; had a register 
with fields identifying donor, recipient, and cash amount; 
provided a register in a format that allowed further 
analysis; and had their register publicly available online. 
Mean attainment was 1.9/5; no NHS trust met all five 
criteria.
Conclusion Overall, recording of employees’ conflicts of 
interest by NHS trusts is poor. None of the NHS Trusts in 
England met all transparency criteria. 19 did not respond 
to our FoIA requests, 51 did not provide a Gifts and 
Hospitality Register and only 31 of the registers provided 
contained enough information to assess employees’ 
conflicts of interest. Despite obligations on healthcare 
professionals to disclose conflicts of interest, and on 
organisations to record these, the current system for 
logging and tracking such disclosures is not functioning 
adequately. We propose a simple national template 
for reporting conflicts of interest, modelled on the US 
‘Sunshine Act’.
IntrODuCtIOn
$2.4 billion was given to US doctors by the 
pharmaceutical industry in 2015.1 48% of all 
doctors in the US received such payments, the 
majority of which were ‘general’ payments 
rather than payments for research. The motive 
for the pharmaceutical industry in spending 
this money is widely held to be marketing.2 In 
the UK the 2015 spend has been reported by 
industry as £111 million, excluding payments 
for research.3 Direct gifts and inducements 
have been prohibited since 2010 by the Asso-
ciation of the British Pharmaceutical Industry 
(ABPI), an industry membership organisation 
that has also become a voluntary regulator of 
the pharmaceutical industry.4 However, phar-
maceutical companies can still pay doctors 
and other clinicians5 6 to deliver Continuing 
Professional Development (CPD) lectures 
or sponsor their attendance at conferences. 
They can directly provide ‘training’ or 
‘updates’ to clinicians, often accompanied 
by generous catering. They can also sponsor 
educational and academic events within 
hospitals, provide restaurant meals, and send 
marketing staff (commonly known as ‘drug 
reps’) to meet with doctors directly. Recent 
systematic reviews7 8 have found an association 
between contact between prescribers and the 
pharmaceutical industry and a decrease in 
strengths and limitations of this study
 ► We included all NHS Trusts in England.
 ► Responding to Freedom of Information Act (FoIA) 
requests is a statutory responsibility: we therefore 
yielded a high (91.9%) response rate.
 ► Trusts who did not respond to our FoIA request 
may have poorer COI disclosure practices: we may 
therefore have underestimated the extent of the 
problems identified.
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their prescribing quality, or an increase in inappropriate 
prescribing and prescribing cost.
Doctors and other healthcare professionals are required 
to declare all financial conflicts of interest so that their 
appropriateness, and any possible impact on professional 
behaviour, can be assessed independently and transpar-
ently. The Physician Payment Sunshine Act (PPSA) Act in 
the US requires that all payments to doctors are declared 
onto a single central database that is openly acces-
sible. UK guidelines are more fragmented. The GMC,9 
and some other professional organisations10 11 require 
healthcare providers to declare any potential conflict of 
interest to both their patients and their employers. NHS 
England circulated ‘Standards of Business Conduct’ to 
NHS trusts in 1993,12 which stipulates that all NHS staff 
‘should’ declare potential conflicts of interest to their 
employers, and that these ‘should’ be recorded in a Gifts 
and Hospitality Register. NHS trusts administer hospitals, 
mental health and specialist community services, and 
employ many of the healthcare professionals in the UK. 
The NHS England guidelines are not binding on trusts, 
although many do incorporate them into local guide-
lines and therefore staff contracts. Industry transparency 
requirements are similarly problematic. In 2016 the ABPI 
released a database of all payments by UK pharmaceutical 
companies to healthcare professionals. However, those in 
receipt of these payments could opt out of having their 
name declared on this database, leaving the payment 
recorded only in aggregate for each company. This, and 
other problems with the database, means that it provides 
an ‘illusion of transparency’ rather than an auditable 
resource.13
Given the problems with industry disclosure it is hoped 
that declarations to NHS trusts might provide a better 
route for transparency around industry payments to 
healthcare professionals. There has never been a system-
atic examination of the existence and contents of these 
registers. We therefore set out to request and describe all 
UK NHS Gifts and Hospitality registers.
MethODs
Our objectives were to: request all COI registers from all 
English NHS trusts; describe whether they were delivered; 
assess the contents and structure of hospitals’ disclosure 
registers; and generate summary statistics describing 
disclosures overall.
Obtaining COI registers
We sent all 236 NHS Trusts in the UK a Freedom of Infor-
mation Act (FoIA) request asking for a copy of their Gifts 
and Hospitality Register for the financial year 2015/16. 
No Trusts were excluded. We also requested the number 
of staff members who have been the subject of internal 
investigations or disciplinary proceedings in relation 
to purported conflicts of interest, or the failure to 
declare them, and the outcomes of these investigations 
or proceedings. The Freedom of Information Requests 
were sent out in the 2 weeks after ninth July 2016. 
Contact details were obtained from each Trust’s website 
and placed into a spreadsheet; a Google Apps script was 
then used to send standardised emails to each Trust.14 We 
logged replies until mid-November 2016. Trusts which 
did not reply were followed up twice. Summary statistics 
are presented on the proportion of Trusts sending their 
COI register in total; and the proportion responding 
within the timescale stipulated by the Act (20 working 
days). We describe the proportion invoking section 12 to 
avoid disclosing (a refusal on grounds of cost), and those 
citing section 40 to remove names from the register (on 
grounds of privacy). We also logged those trusts who 
directed us to the ABPI’s summary disclosure database 
on which healthcare professionals can choose to have 
their payments anonymised.
Assessing the contents and structure of hospitals’ disclosure 
registers
We extracted the following structured data to describe 
the contents of each hospital’s disclosure register: the 
format the information was delivered in (PDF, docu-
ment, spreadsheet, scans of handwritten sheets, or text 
within an email); and the completeness of information 
given about each individual disclosure (the name of the 
recipient, the name of the company providing the gift or 
hospitality, the cash amount of the gift). In addition, we 
noted whether the register was already publicly available 
online. We also checked each register for any identifying 
patient data. We generated summary statistics to describe 
these contents. Data extraction was performed by one 
of the authors (HRF). Standards and classifications 
were discussed with other authors (NJD and BG) before 
data were extracted. We generated a transparency index 
assessing whether each Trust met the following criteria: 
(1) responded on time; (2) provided a register; (3) had a 
register with fields identifying donor, recipient, and cash 
amount; (4) provided a register in a format that allowed 
further analysis; and (5) had their register publicly avail-
able online.
summary statistics on disclosures
Because the data provided was in multiple formats, and 
frequently not structured, it could not be aggregated 
for analysis. One author (HRF) manually transcribed 
data from a random sample of 20 Trust’s disclosures and 
generated summary statistics on: the number of disclo-
sures per Trust; the size of each individual disclosure; the 
profession of those making disclosures; and the source of 
the payment (industry or patient). This sample size was 
chosen to represent approximately 10% of disclosures, 
and was limited by researcher time. Where names of staff 
were given but not job roles, organisation web pages were 
used to try to ascertain the profession of the individual 
making the disclosure. The field of commercial entities 
was ascertained through their company webpages. Where 
a range of cash values were given (eg, ‘<£50’) the upper 
value was used.
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Analysis
All analyses were conducted in Google Sheets.
Patient involvement
No patients were involved in setting the research question 
or the outcome measures, nor were they involved in the 
design or conduct of the study. No patients were asked to 
advise on interpretation or writing up of results. There 
are no plans to disseminate the results of the research to 
study participants.
results
Obtaining trust disclosure registers
Of the 236 trusts sent a Freedom of Information request, 
217 responded (91.9%). 185 Trusts (78.4%) provided a 
copy of their Gifts and Hospitality register for the finan-
cial year 2015/16. 10 Trusts (4.2%) declined to share 
their disclosure register and invoked Section 12 of the 
FoIA, an exemption available where a public body can 
assert that the cost of collating and sharing information 
would exceed £450. Other reasons given for not providing 
a Gifts and Hospitality register included: no register was 
held (18/217, 8.3%); the register contained no entries 
(5/217, 2.3%); the register was on paper only (5/217, 
2.3%); and other reasons (3/217, 1.3%). Of those trusts 
that did not hold a register, two claimed it was not needed 
because their staff were contractually prohibited from 
accepting such payments, and six Trusts sent data from 
the ABPI instead. In three of these cases, a version of the 
ABPI database was sent with the names of the recipients 
redacted, even though this information is freely avail-
able online with names unredacted. 12 Trusts (5.5%) 
suggested that we refer to the ABPI database for further 
or more complete information.
Contents and structure of hospitals’ disclosure registers
Of the 185 registers received, only 31/185 (16.7%) were 
complete – containing fields recording the name of the 
recipient, the name of the donor and the cash amount 
received. However, even when there were fields to record 
these data, incomplete records were common. 126 regis-
ters (68.1%) did not have a field for the name of the 
recipient. 14 Trusts (7.6%) explicitly stated that they had 
redacted this field under Section 40 of the Freedom of 
Information Act, arguing that it constituted personal 
information. Some Trusts redacted only the names of 
staff under a certain pay band. 59 registers (31.9%) did 
not have a field for the name of the donor. 47 registers 
(25.4%) did not have a field for the cash value of the 
gift or hospitality. The overlap between these elements is 
shown in a Venn diagram in figure 1. Of note, 18 registers 
(9.7%) contained none of: recipient name, donor name, 
or declaration of the cash amount received.
The proportion of Trusts meeting each of our five trans-
parency criteria is given in table 1; the distribution of the 
total number of criteria met is given in figure 2. Mean 
attainment was 1.9/5. No NHS trust met all five criteria.
breaches of patient confidentiality in trust responses
11/185 (5.9%) of the registers contained information 
which could potentially breach patient confidentiality - for 
example, giving the name of the patient or relative who 
had given a gift to a healthcare professional. To protect 
patients’ confidentiality we have therefore removed the 
disclosures made by these Trusts from our shared dataset.
Data on disciplinary hearings
199 trusts returned information on the number of disci-
plinary hearings related to conflict of interest. Of these, 
174 had had none. The mean number per Trust was 0.2. 
The definition of ‘conflict of interest’ was interpreted 
broadly by Trusts and included actions such as having a 
second job and working while on sick leave.
summary statistics on disclosures
Data from 20 trusts was transcribed into spreadsheet 
format to produce summary statistics. The registers tran-
scribed contained a mean of 30.8 entries (range 4–175, 
total 616). 428 entries gave the cash amount of the decla-
ration, totalling £162,245 - a mean declaration size of 
£379. However, there was substantial rightward skew with 
a median declaration of £127.50 and 122 entries with 
Figure 1 Venn diagram showing the information contained 
in the registers received.
Table 1 Number and percentage of trusts achieving each 
transparency criteria
Transparency element
Number 
of trusts 
achieving 
criteria
Proportion 
of trusts 
achieving 
criteria
Responded on time 165 69.9%
Provided a register 185 78.4%
Contained fields for named 
donor, named recipient and 
cash amount
31 13.1%
Provided the register in a 
format that allowed further 
analysis (ie, spreadsheet, 
csv)
53 22.5%
Made register publicly 
available online
15 6.4%
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value £30 or less. Further data about the sources and 
recipients of the payments on these registers is shown in 
figure 3.
trusts with a ‘zero’ disclosure
Unexpectedly, five trusts stated that they had no entries on 
their register, and another two delivered empty registers. 
For those trusts which described or returned no entries, 
we found 230 records in the ABPI disclosure database 
relating to payments to individuals employed at these 
Trusts, totalling £119,851.35. In addition, we found 107 
records of payments to these trusts directly, an average of 
£22 293 per trust.
Two of these trusts stated that a disclosure register was 
not needed as their policies prohibited staff from taking 
such payments. One, East London Foundation Trust, 
stated: ‘Trust Policy prohibits the acceptance of payments from 
pharmaceutical companies to members of staff. We therefore have 
no such register.’ A search of the ABPI database (dated 
19/04/2017) returned 7 payments to five individuals 
who registered their institution as East London Founda-
tion Trust, with a total value of £2050.63. Hertfordshire 
Community NHS Foundation Trust stated: ‘We do not 
have a ‘gifts’ register, as under the Trust’s Standards of Business 
Conduct Policy (previously supplied) a gift is either acceptable 
(in which case it doesn’t need to be reported) or it is not accept-
able.’ A search of the ABPI database returned 5 payments 
to four individuals who registered their institution as 
Hertfordshire Community NHS Foundation Trust, total-
ling £734.43. Since clinicians are permitted to withhold 
disclosure of their data on the ABPI, and non-disclosure 
rates on the ABPI database are high, this is likely to be an 
incomplete list.
Data sharing
All responses15 and all analyses16 are shared on FigShare. 
Where we have concerns that Trusts have breached 
patient confidentiality in their returns, we have redacted 
any potential personal information. In order to illustrate 
the issues described in summary text above we have also 
shared a range of illustrative examples17: an example of a 
register which mostly lists trivial gifts from patients (3.1), 
a register which mostly discloses additional employment 
(3.2), a register which covers only board members and 
not staff (3.3), and data structure which is almost impen-
etrable to analysis and audit (3.4).
Figure 2 Distribution of total number of transparency criteria met, across all NHS Trusts.
Figure 3 Recipients and sources of the payments disclosed 
in the 20 randomly selected registers we quantified.
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We have set up a new website ( coi. theycareforyou. org), 
to make data on Trusts' COI declarations more accessible 
for all interesed parties; all data from our paper is shared 
accessibly here. NHS Trusts are welcome to submit their 
most up-to-date register to this site.
COnClusIOn
summary of findings
Overall, recording of the interests of employees by NHS 
trusts is poor. None of the NHS Trusts in England met 
all transparency criteria by: (1) responding on time; (2) 
providing a register; (3) that register having a complete 
data structure; (4) providing the data in a reusable 
(spreadsheet) format; (5) making the register publicly 
available online. 59/185 trusts did not record the donor 
of the payment or hospitality, which makes it impossible 
to assess the conflict of interest. 18 trusts did not hold a 
disclosure register at all.
strengths and limitations of the study design
The use of a statutory framework - the Freedom of Infor-
mation Act (FoIA) - led to a very high (91.9%) response 
rate in this study. The presence of missing data is in itself 
informative: responses that were absent or incomplete 
are an important finding. However, it is possible that 
Trusts which failed to respond to a FoIA request are also 
failing on other administrative issues. The absence of 
their disclosures may result in our study underestimating 
the problems with Trust registers by only coding those 
from Trusts which did respond.
Findings in context
We have previously outlined the problems with the ABPI’s 
‘Disclosure UK’ as a platform for reporting conflicts of 
interest in particular that healthcare professionals can 
choose to redact themselves from that dataset, and 
routinely do so.13 Barriers to accessing UK COI data mean 
that there is little prior work analysing such disclosures. In 
the US, disclosures are managed on a national level by the 
federal government. The PPSA was passed as part of the 
Patient Protection and Affordable Care Act in 2010.18 The 
PPSA requires industry to report all payments to doctors 
(but not other healthcare professionals, who also receive 
significant attention from pharmaceutical marketing5 6) 
and teaching hospitals in excess of $10, to the Centres 
for Medicare and Medicaid Services (CMS). This includes 
payments for ‘general’ categories such as educational 
materials or food and beverage, as well as funding for 
research and ownership stakes in the reporting entities. 
CMS then makes this data available through the publicly 
searchable Open Payments website. The Open Payments 
website19 currently houses all reported payments from 
first August 2013 to 31 st December 2016. Over this time, 
the Open Payments database has grown to include details 
of nearly $25 billion worth of payments to doctors and 
teaching hospitals including $7 001 435 854 in general 
payments to 9 05 238 individual doctors. For the full 3.5 
years covered by the PPSA, the mean number of general 
(non-research) payments to doctors is 43 and the mean 
amount received from these payments is $7734.36.20
The comprehensive and accessible nature of Open 
Payments has allowed researchers to assess and quantify 
the impact of pharmaceutical payments. For example, 
there is a dose-response relationship between receiving 
more pharmaceutical payment and increased prescribing 
cost21 and branded drug prescribing,22 which has been 
demonstrated by linking publicly available Medicare 
prescribing data with Open Payments data.23 Others 
have used the data to characterise industry payments 
within their specialty24 25 or auditing targeted groups 
such as guideline authors.26 27 While the programme is 
still new, there is evidence that industry spending may 
be decreasing since the launch of Open Payments.28 29 
Some researchers are even beginning to use PPSA data to 
examine association between relationships with industry 
and clinical practice.30 The public availability of the data 
has also been an asset to investigative journalism into the 
medical profession.31 32
However, the PPSA and Open Payments have faced criti-
cisms. They exclude non-doctor prescribers from required 
reporting5 6 33 and have been unpopular with some 
doctors for a variety of reasons.34 As the US experience 
shows, creating centralised and standardised disclosure 
databases for physicians presents challenges around how 
to collect, validate, and present data in accurate, useful, 
and meaningful ways. These difficulties, however, should 
not dissuade attempts to improve on the current status 
quo on countries like the UK. As our findings show, when 
disclosure is required only through broad, unspecific, 
and unenforced regulations its utility and accessibility 
is greatly compromised. Efforts like the ABPI database 
also fall short of a programme like Open Payments as 
it is a voluntary endeavour without the authority of the 
state to require reporting and compel compliance. These 
limitations preclude the prospect of any comprehensive 
research on the state of COI in the UK, an area that is 
flourishing in the US among more comprehensive disclo-
sure standards and despite programmatic limitations.
Interpretation and policy implications
The current system of piecemeal private declarations to 
NHS employers, and optional declarations through the 
ABPI’s ‘Disclosure UK’, is not delivering transparency on 
COI in the UK. Through our analysis of these records, we 
identify four main barriers to transparency.
First, there is no central system for disclosures to 
employers. This allows wide variations in the standards 
of reporting and recording COI. Many healthcare 
professionals will also have more than one public sector 
employer simultaneously, or sequentially over a short time 
period. Declaring separately with each employer makes it 
unlikely that any one organisation will have access to full 
information about their employees. Second, there is poor 
auditing of records, and a lack of evidence that contents 
are reflected on locally. Most Trusts allowed incomplete 
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records to be returned, seemed not to compare their decla-
rations with other sources such as the ABPI database, and 
appeared happy to accept implausibly empty registers. If 
this information is collected but not examined or acted 
on, there is a risk that this gives an unwarranted appear-
ance of transparency and rigorous management. Thirdly, 
the variation in types of information disclosed and how it 
was presented suggests that there is lack of clarity about 
what constitutes a COI; and a lack of consensus around 
how to handle diverse categories of COI such as income 
from private work, interactions with industry, and gifts 
from patients. Lastly, COI records are generally not made 
public. Most Trusts did not place their registers on the 
internet, and most did not give the names of recipients 
on their COI register.
Some NHS Trusts cited the Freedom of Information Act 
as a reason to withhold the identity of recipients, specifi-
cally Section 40 of the Act, which aims to protect individ-
uals’ personal privacy. In our view there are good grounds 
to argue that this is not a legitimate use of Section 40: 
employees were largely acting in a professional capacity 
when they received payments; disclosure represents a 
legitimate public interest; FoIA emphasises the impor-
tance of ‘transparency and accountability’ when consid-
ering personal data disclosure; healthcare professionals 
have existing disclosure obligations to professional regu-
lators (for example, the GMC requires doctors to inform 
their patients about any conflicts of interest); and staff 
expectations at the time of disclosure to a Trust are there-
fore likely to have been that this COI information should 
or could be made public. These issues can be resolved 
through an extensive process of appeals to the Informa-
tion Commissioner, although this process may take years 
rather than months.
On ninth February 2017, NHS England published new 
guidance about managing conflict of interest within the 
NHS.35 This guidance aims to offer more complete and 
consistent principles for managing COI in NHS Trusts, 
CCGs and NHS England. The guidance emphasises that 
declarations must be collected and recorded, and recom-
mends that the declarations of 'decision-making staff' are 
published (with names) on an organisation’s website. 
However, it is not binding on Trusts, and each organisa-
tion is free to adopt whatever standards it wishes. There 
is no proposal that the data should be centralised. The 
template disclosures ask for a ‘description’ of the interest 
in a single text field meaning that information can be 
omitted, or shared as unstructured free text, meaning 
that work done in the US on structured open data would 
continue to be impossible for UK disclosures. There is 
no guidance on identifying and managing the impact of 
pharmaceutical gifts and hospitality on prescribing. The 
new NHS COI policy would therefore not resolve the lack 
of transparency identified by our study.
We propose that the UK should ideally follow the lead 
set by the US, requiring simple annual compulsory disclo-
sure of all financial COI by NHS healthcare professionals 
and donors to a central openly accessible database of 
COI, recording cash value, type of COI, donor, and recip-
ient. Short of this, the GMC could remind doctors and 
Trusts that they expect the GMC requirement for open 
disclosure of COIs to patients to be upheld, and clarify 
that complete and openly shared NHS Trust COI regis-
ters allow doctors to meet their GMC requirements. This 
could be done with no changes to either legislation or the 
GMC document ‘Good Medical Practice’, which states: 
‘you must be honest in financial and commercial deal-
ings with patients employers, insurers and other organisa-
tions or individuals’ and ‘if you are faced with a conflict of 
interest, you must be open about the conflict, declaring 
your interest formally.’
Lastly, since COI is an issue for all those working in 
healthcare, not only doctors, we propose that it would be 
desirable to create and encourage the use of an openly 
accessible voluntary register where any healthcare profes-
sional, manager, or researcher in the UK could openly 
log their conflicts of interest in a structured searchable 
format as has been previously proposed for researchers 
in various territories.36–38 We are now seeking funds to 
deliver and maintain such a database.
Future directions
We aim to repeat this study to assess the impact of the 
new NHS guidance on disclosure, while acknowledging 
that such change is unlikely for the reasons given above. 
We also aim to expand our study to include Primary Care, 
where 55% of UK prescribing costs occur,39 by assessing 
the recording of COI by Clinical Commissioning Groups 
(CCGs). This has received attention recently after an 
audit in April 2016 showed that COI were inconsistently 
recorded within CCGs, and new binding guidance was 
released in July 2016.40
Conclusions
Information on COI is poorly collected, poorly managed, 
and poorly disclosed by NHS Trusts in England. The 
ongoing absence of transparency around COI in the UK 
may undermine public trust in the healthcare profes-
sions. Simple clear legislation and a requirement for 
open disclosure of COI to a central body, similar to that 
in the US, would present a simple and effective solution.
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